Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27042062 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Arslan Amer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, Selenium, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) shows substantial heterogeneity in cysteine dependence and ferroptosis sensitivity. We identify two PDAC subtypes distinguished by EMT status: mesenchymal-like cells are highly cysteine-dependent and rapidly undergo ferroptosis upon cystine deprivation or system xc− inhibition, whereas epithelial-type cells are ferroptosis-resistant. Selenium supplementation protects cells from erastin-induced ferroptosis, and this protection persists even when intracellular glutathione (GSH) is depleted, supporting an additional GPX4-independent protective mechanism. Sepp1 knockdown does not alter sensitivity, indicating that selenium’s protective effect is independent of Sepp1. Instead, epithelial-type cells rely on both cytosolic and mitochondrial thioredoxin reductases (TrxR1 and TrxR2) to maintain ferroptosis resistance. Chemical inhibition of thioredoxin reductases abolishes selenium-mediated protection and sensitizes epithelial cells to ferroptosis inducers, while dual genetic suppression of TrxR1 and TrxR2 similarly restores ferroptosis sensitivity. These findings uncover a selenium–thioredoxin redox axis that functions independently of GPX4 and contributes ferroptosis resistance in epithelial-type PDAC cells. Co-targeting cysteine metabolism and thioredoxin reductases may therefore represent a rational strategy to overcome ferroptosis resistance in some PDAC subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA.
ORCID-Profile: Micah Idowu
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Amer, A., Idowu, M., Ahsan, A., Abbas, A., Alothaim, T., & Tang, X. (2026). Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042062
Vancouver
Amer A, Idowu M, Ahsan A, Abbas A, Alothaim T, Tang X. Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042062
BibTeX
@article{Amer2026,
author = {Amer, Arslan and Idowu, Micah and Ahsan, Aqsa and Abbas, Alyssa and Alothaim, Tahiyat and Tang, Xiaohu},
title = {Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27042062}
}
EUVIMED